SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001137439-21-000195
Filing Date
2021-03-29
Accepted
2021-03-29 16:41:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 haft13d032021.htm SC 13D 47286
2 ex991.htm EX-99.1 26989
  Complete submission text file 0001137439-21-000195.txt   75558
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Subject) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92403 | Film No.: 21782185
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FINCH THERAPEUTICS GROUP, INC. 200 INNER BELT ROAD, SUITE 400 SOMERVILLE MA 02143
Business Address
Haft Nicholas (Filed by) CIK: 0001850404 (see all company filings)

Type: SC 13D